Nicolas Barthelemy

Track

Insider profile

Currently holds a position at Twist Bioscience Corp

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 47% 68% 82%
Transactions
11 36% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Director Twist Bioscience Corp Oct. 24, 2019 -
Nicolas Barthelemy's trades of Repligen Corp's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Repligen Corp (RGEN)
Transaction date
Purchase
Price
376.88
Quantity 61,395 +46.8%
Value US$2,296,546
Transaction date
Purchase
Price
103.71
Quantity 96,714 +6.4%
Value US$2,906,407
US Repligen Corp (RGEN)
Transaction date
Sale
Price
75.90
Quantity 62,846 +2.4%
Value US$3,723,289
US Repligen Corp (RGEN)
Transaction date
Sale
Price
288.20
Quantity 1,285 -40.3%
Value US$370,337
Transaction date
Planned sale
Price
40.00
Quantity 4,000 -100.0%
Value US$160,000
Transaction date
Planned sale
Price
39.53
Quantity 3,000 -100.0%
Value US$118,590
Transaction date
Planned sale
Price
39.63
Quantity 6,000 -30.7%
Value US$237,780
Transaction date
Purchase
Price
20.00
Quantity 14,000 +inf%
Value US$280,000
US Repligen Corp (RGEN)
Transaction date
Sale
Price
195.51
Quantity 1,214 -45.6%
Value US$237,349
US Repligen Corp (RGEN)
Transaction date
Sale
Price
142.53
Quantity 3,009 -53.0%
Value US$428,873
US Repligen Corp (RGEN)
Transaction date
Sale
Price
109.99
Quantity 2,688 -47.0%
Value US$295,653
US Repligen Corp (RGEN)
Transaction date
Sale
Price
99.99
Quantity 2,688 -39.8%
Value US$268,773
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-06-14 2024-06-14
US Repligen Corp (RGEN)
B Purchase
61,395 +46.8%
376.88
US$2,296,546 		61,395 +46.8% 376.88 US$2,296,546
2022-05-13 2022-05-11
B Purchase
96,714 +6.4%
103.71
US$2,906,407 		96,714 +6.4% 103.71 US$2,906,407
2021-11-02 2021-10-29
US Repligen Corp (RGEN)
S Sale
62,846 +2.4%
75.90
US$3,723,289 		62,846 +2.4% 75.90 US$3,723,289
2021-11-02 2021-10-29
US Repligen Corp (RGEN)
S Sale
1,285 -40.3%
288.20
US$370,337 		1,285 -40.3% 288.20 US$370,337
2021-06-25 2021-06-24
PlS Planned sale
4,000 -100.0%
40.00
US$160,000 		4,000 -100.0% 40.00 US$160,000
2021-06-25 2021-06-23
PlS Planned sale
3,000 -100.0%
39.53
US$118,590 		3,000 -100.0% 39.53 US$118,590
2021-06-25 2021-06-23
PlS Planned sale
6,000 -30.7%
39.63
US$237,780 		6,000 -30.7% 39.63 US$237,780
2021-02-11 2021-02-09
S Sale
5,000 -72.5%
177.61
US$888,034 		5,000 -72.5% 177.61 US$888,034
2020-12-22 2020-12-22
B Purchase
14,000 +inf%
20.00
US$280,000 		14,000 +inf% 20.00 US$280,000
2020-11-10 2020-11-09
US Repligen Corp (RGEN)
S Sale
1,214 -45.6%
195.51
US$237,349 		1,214 -45.6% 195.51 US$237,349
2020-05-26 2020-05-18
US Repligen Corp (RGEN)
S Sale
3,009 -53.0%
142.53
US$428,873 		3,009 -53.0% 142.53 US$428,873
2020-04-24 2020-04-22
US Repligen Corp (RGEN)
S Sale
2,688 -47.0%
109.99
US$295,653 		2,688 -47.0% 109.99 US$295,653
2020-04-06 2020-04-03
US Repligen Corp (RGEN)
S Sale
2,688 -39.8%
99.99
US$268,773 		2,688 -39.8% 99.99 US$268,773
2020-03-10 2020-03-06
B Purchase
80,000 +115.3%
3.05
US$243,872 		80,000 +115.3% 3.05 US$243,872
2020-02-18 2020-02-13
B Purchase
12,257 +21.5%
3.64
US$44,614 		12,257 +21.5% 3.64 US$44,614
2019-06-19 2019-06-17
PlS Planned sale
5,100 -10.9%
12.43
US$63,398 		5,100 -10.9% 12.43 US$63,398